Seyda N. Kalın

Erzurum, 25240, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Evernic and diffractaic acids: Novel regulators of intracellular redox homeostasis in the MCF-7 cell line.

Evernic and diffractaic acids: Novel regulators of intracellular redox homeostasis in the MCF-7 cell line.

Journal: Molecular biology reports

Published: April 19, 2026

Design, synthesis, in vitro and in silico evaluation of thiazole-hydrazine hybrids incorporating an isoindole-1,3-dione scaffold as potent α-glucosidase inhibitors.

Design, synthesis, in vitro and in silico evaluation of thiazole-hydrazine hybrids incorporating an isoindole-1,3-dione scaffold as potent α-glucosidase inhibitors.

Journal: Bioorganic chemistry

Published: January 31, 2026

Pro-oxidant effect of lobaric acid as a therapeutic strategy against breast cancer: a molecular perspective.

Pro-oxidant effect of lobaric acid as a therapeutic strategy against breast cancer: a molecular perspective.

Journal: Molecular biology reports

Published: January 23, 2026

Inhibition of thioredoxin reductase 1 by evernic and vulpinic acids: a promising anticancer strategy on A549 cells.

Inhibition of thioredoxin reductase 1 by evernic and vulpinic acids: a promising anticancer strategy on A549 cells.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: May 06, 2025

Lobaric Acid Exhibits Anticancer Potential by Modulating the Wnt/β-Catenin Signaling Pathway in MCF-7 Cells.

Lobaric Acid Exhibits Anticancer Potential by Modulating the Wnt/β-Catenin Signaling Pathway in MCF-7 Cells.

Journal: Pharmacology research & perspectives

Published: March 02, 2025

Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1.

Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: October 13, 2023

Antiproliferative, antimigratory, and apoptotic effects of diffractaic and vulpinic acids as thioredoxin reductase 1 inhibitors on cervical cancer.

Antiproliferative, antimigratory, and apoptotic effects of diffractaic and vulpinic acids as thioredoxin reductase 1 inhibitors on cervical cancer.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: August 02, 2023

Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells.

Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells.

Journal: Journal of applied toxicology : JAT

Published: February 21, 2023

Effect of evernic acid on human breast cancer MCF-7 and MDA-MB-453 cell lines via thioredoxin reductase 1: A molecular approach.

Effect of evernic acid on human breast cancer MCF-7 and MDA-MB-453 cell lines via thioredoxin reductase 1: A molecular approach.

Journal: Journal of applied toxicology : JAT

Published: January 10, 2023

Inhibition of thioredoxin reductase 1 by vulpinic acid suppresses the proliferation and migration of human breast carcinoma.

Inhibition of thioredoxin reductase 1 by vulpinic acid suppresses the proliferation and migration of human breast carcinoma.

Journal: Life sciences

Published: June 28, 2022

Tip60/Kat5 may be a novel candidate histone acetyltransferase for the regulation of liver iron localization via acetylation.

Tip60/Kat5 may be a novel candidate histone acetyltransferase for the regulation of liver iron localization via acetylation.

Journal: Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine

Published: March 16, 2022

Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells.

Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells.

Journal: Chemico-biological interactions

Published: November 23, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026